Schlagwort: European biotech
Part III: The Best Asset Doesn’t Have a Passport
For many years, Western biotech companies viewed China primarily as a manufacturing base and, increasingly, as an attractive commercial market. Today, that perspective is...
AI in pharma/biotech fundraising, partnering and finance
AI tools for fundraising, business development and finance are now widely available. However, there appears to be a gap between larger pharma companies which...
Are European Life Sciences Startups in Trouble?
Investment in the life sciences sector is facing challenges, with fewer deals and increasing market uncertainty. Despite these difficulties, however, investment volumes are on...


